rna-rna interactions have critical roles in many cellular processes, but studying them is difficult and laborious. Here we describe an experimental procedure, termed cross-linking ligation and sequencing of hybrids (clasH), which allows high-throughput identification of sites of rna-rna interaction. During clasH, a tagged bait protein is uV-cross-linked in cell cultures to stabilize rna interactions, and it is purified under denaturing conditions. rnas associated with the bait protein are partially truncated, and the ends of rna duplexes are ligated together. after linker addition, cDna library preparation and high-throughput sequencing, the ligated duplexes give rise to chimeric cDnas, which unambiguously identify rna-rna interaction sites independent of bioinformatic predictions. this protocol is optimized for studying mirna targets bound by argonaute (aGo) proteins, but it should be easily adapted for other rna-binding proteins and classes of rna. the protocol requires ~5 d to complete, excluding the time required for high-throughput sequencing and bioinformatic analyses.
IntroDuctIon
The crucial role of RNA interactions in many cellular processes, including translation and splicing, has long been well established. However, interest in the identification of targets for RNA inter actions has been increased by a slew of recent discoveries, includ ing the regulatory potential of miRNAs and long noncoding RNAs (lncRNAs) and the direct participation of RNA in transcription regulation (for recent reviews see refs. 1-3). Moreover, advances in sequencing technology have highlighted the startling complex ity of the transcriptome and revealed everincreasing numbers of different RNA species. Deep sequencing has revealed that most of the eukaryotic genome is transcribed 4 , but the biological func tions of the majority of transcripts remain unclear.
Many RNA species function via interactions with pro teins and/or other RNA molecules. A key advance in high throughput analyses of ribonucleoprotein (RNP) complexes was the development of the CLIP technique (crosslinking and immunoprecipitation) by the Darnell laboratory 5 . CLIP is based on the stabilization of proteinRNA complexes in their cellular environment by UV crosslinking, immunoprecipitation of RNPs and the isolation and sequencing of bound RNAs. Many modi fications of CLIP have subsequently been reported, including HITSCLIP (highthroughput sequencing of RNA isolated by CLIP) 6 , PARCLIP (photoactivatableribonucleosideenhanced CLIP) 7 and iCLIP (individualnucleotide resolution UV CLIP) 8 . Originally applied to the neuronal splicing factor Nova, CLIP based techniques have allowed the characterization of the RNA targets for many proteins. Although all these techniques directly reveal only proteinRNA interactions, the data can greatly aid bioinformatic predictions of RNARNA interactions. The first experimentally supported highthroughput prediction of miRNA targets was achieved by HITSCLIP analyses of the AGO family of miRNAbinding proteins 9 .
The CLASH technique described here is the first reported high throughput method for the direct identification of RNARNA interactions. It was derived from a further modified version of CLIP called CRAC (UV crosslinking and analysis of cDNAs) 10 . In CRAC, the immunoprecipitation step is replaced by purification of tandem tagged proteins on an affinity resin. This eliminates the necessity for highaffinity antibodies and allows for very stringent purification of RNPs under denaturing conditions. This ensures a low recovery of background RNA and allows the analysis of individual proteins within very stable complexes (e.g., pre ribosomes) that would resist the semidenaturing conditions used in CLIP approaches. In the course of CRAC experiments performed on the proteins binding to small nucleolar RNA (snoRNA)rRNA duplexes, we observed that a small proportion of the RNARNA hybrids were ligated together and gave rise to chi meric cDNAs in the sequencing data (Fig. 1) . CLASH was initially developed as a bioinformatic pipeline for the analysis of these chimeras, and it allowed the direct identification of interacting RNA molecules and their structures 11 . We subsequently enhanced the efficiency of chimera recovery in CLASH analyses by modify ing the experimental protocol, with a crucial additional ligation step allowing enrichment for RNARNA chimeras. CLASH allows the identification of RNARNA interactions without bioinfor matic predictions, and we recently applied it to the characteriza tion of the human miRNA interactome 12 .
miRNAs are short noncoding RNAs that are involved in the post transcriptional regulation of gene expression. Bound by AGO pro teins, they direct effector RNP complexes to the target RNAs by means of complementarity. Each miRNA can bind many targets and each target can be regulated by multiple miRNAs, thus creating a huge network of interactions and mutual dependencies between RNA molecules. The patterns of miRNA-target mRNA basepairing have been extensively studied, but many known interactions match poorly with the established canonical rules (for a review, see ref. 13 ). Defining more comprehensive miRNA targeting rules requires an experimental method that is independent of preexisting knowledge and assumptions. By using CLASH for this purpose, we identified more than 18,000 miRNAmRNA interactions, revealing a broad picture of the miRNA interactome in HEK 293 cells 12 . This protocol is specifically adjusted for studying miRNA targets bound by AGO proteins. It should, however, be readily adjusted for other RNA binding proteins and types of RNA, as discussed further below.
Overview of the procedure Living cells expressing PTH (protein A-tobacco etch virus (TEV)
cleavage site-6×His)tagged AGO are UVirradiated (254 nm) to covalently couple existing proteinRNA complexes. Cells are lysed, PTHtagged AGO is stringently purified under denaturing conditions, proteinbound RNARNA duplexes are trimmed by RNases and interacting RNA strands are ligated together to form chimeric guide-target molecules (Fig. 2) . All AGOinteracting RNAs are subsequently isolated and used to produce a cDNA library ready for Illumina sequencing.
Bioinformatic analyses of CLASH data provides two types of information: precise AGObinding sites on RNAs (similar to information obtained from CRAC or CLIP methods) and RNARNA hybrids that are formed within the AGO RNAbinding pocket (specific to the CLASH technique). Another limitation of the current pro tocol arises from the low efficiency of RNARNA ligation. The number of chi meric reads in the sequencing data is quite variable and usually lower than 2% of all sequencing reads. A good cDNA library obtained with the current protocol is expected to yield ~15,000 unique miRNA mRNA interaction sites. This is a substantial number, but it does not saturate miRNA interactions in cells. A reliable comparison of alterations in miRNA targets under changing physiological con ditions would require more complete coverage. Obtaining even higher numbers of RNARNA hybrids from each sample should therefore be a priority in the next optimization stages.
Advantages of the method
Applications and future uses of the method AGOCLASH is the method of choice for looking for new phenomena in miRNA biology: observation of new patterns of target binding and identification of novel targets or RNA regulators. Additional modifications to increase the efficiency of RNARNA ligation (as discussed below) would facilitate a range of applications, such as studying the dynamics of miRNA interactions in changing physiological conditions, the influences of diverse miRNA modifications on targeting efficiency or comparing targets of various miRNA family members.
As CLASH uses a simple concept of creating chimeric RNAs from two interacting RNA molecules, it should be easily applied to studies of various biological processes that involve ternary complexes, e.g., RNAbinding protein and two interacting RNA molecules. Depending on the initial phosphorylation state or modifications of the ends of interacting RNA molecules, differ ent orders of the enzymatic reactions should be considered (see 'Preparing RNA ends for ligation' below). In some cases, linker mediated ligation may give better results than a direct guide:target RNA ligation strategy.
In the case of miRNAs, the interacting RNA molecules form a basepaired duplex that is buried within the AGO protein.
However, this structural arrangement is not essential, as inter actions between snoRNAs and their rRNA targets can be identi fied by CLASH using proteins that bind adjacent to the RNA duplex 11 . CLASH is particularly suited to analyses in which one protein binds to a wide variety of RNARNA duplexes. Possible future applications include the identification of targets for the many lncRNAs, and interactions between miRNAs and lncRNAs have already been identified in this way 12 . PremRNA pack aging factors or hnRNP proteins might be suitable as bait proteins for these CLASH analyses. The large data sets generated are also likely to be of value in training future biophysical computational models of miRNAmRNA interactions.
Experimental design
Initial preparation steps: tagging of AGO1. In ref. 12 , we used the AGO1 pro tein with a tripartite tag (PTH) added at the N terminus. This consists of (i) two immunoglobulinbinding Z domains from Staphylococcus aureus protein A; (ii) a TEV protease cleavage site; and (iii) a 6×His tag (Fig. 2) . However, in the protocol, we do not include a TEV cleavage step for the following reasons. First, we observed that 6×HisAGO1 generated by the TEV cleav age is retained by the remaining protein AIgGDynabeads complex. As endogenous AGO1 does not bind IgGDynabeads, this suggests that this retention is caused by a nonspecific binding of AGO1 to the cleaved protein A region of the tag, which is retained on the column. Second, per forming RNARNA ligation directly after TEV cleavage, without AGO1 denatura tion and additional stringent purification on NiNTA, substantially reduced ligation efficiency and increased the background of the method. Instead, we elute AGO1RNA complexes from IgGDynabeads using denaturing conditions. We believe that the only part of the PTH tag crucial for the success of the CLASH method is the 6×Histag, and the first purification step (purification on IgGDynabeads, Steps 8-15) can be performed using any good efficiency tag in place of Protein A. A FLAG-PreScission cleavage site-6×His tag was successfully tested in the laboratory for proteins other than AGO1. Good antibodies should also be suitable for the first purification step, but this has not yet been confirmed.
Initial preparation steps: cell culture. The first stage of the CLASH technique, which is not described in detail in this pro tocol, is the preparation of cells expressing the tagged protein.
In our experiments, we used the FlpIn TREx 293 cell line stably transfected with pcDNA5/FRT/TO vector (Flp recombination tar get site, tetracyclineregulated TetO 2 promoter), expressing PTH tagged human AGO1 upon induction with doxycycline (described in detail in ref. 12 ). However, transient transfection of 293 cells and possibly other cell lines is also a potential option.
Purification of AGO complexes (Steps 8-15 and Steps 23-29).
Stringent purification of the AGORNA complexes before the RNARNA ligation step is very important for the success of the CLASH procedure. ProteinRNA crosslinking is not an effi cient process, and we expect that almost all of the recovered interactions originate from complexes where one RNA strand is crosslinked to AGO and the other RNA molecule is main tained by RNARNA basepairing. Therefore, one of the main concerns is to what extent the RNARNA interactions are sta ble throughout the procedure and how much background arises from random RNARNA interactions formed after cell lysis. For that purpose, we prepared a control experiment with mixed human and yeast lysates, looking for the interspecies chimeric sequences (described in more detail in ref. 12) . For this proto col, the background appeared to be <2%; however, for the alter native protocol with less stringent purification (no guanidine hydrochloride wash before RNARNA ligation), it was close to 10%.
To minimize the background, we used highly denaturing 6 M guanidine hydrochloride in this protocol, possibly sacrificing the numbers of identified RNARNA interactions and creating bias Oligonucleotide design. The 5′ adapters for cDNA cloning car ried a 5′ blocking group (inverted dideoxythymidine; invddT) followed by four DNA residues, an RNA sequence complemen tary to primers present on Illumina sequencing plates, three ran dom ribonucleotides to allow PCR duplicates to be identified and a 5-7 ribonucleotide bar code to allow multiple samples to be sequenced together. The L5 adapters and P5 PCR primer described here are generally applicable to various bait proteins and RNA types. However, any other adapterprimer set used successfully in similar experiments and Illumina sequencing could probably be used.
Preparing RNA ends for ligation (Steps 30-33).
In the AGO CLASH protocol, we take advantage of the short length of miRNAs that tend not to be trimmed by RNases and therefore retain their natural 3′OH ends. These miRNAs do not have to be enzymatically modified for RNARNA ligation (the expected phos phorylation state of RNA molecules along the CLASH protocol is depicted in Fig. 2) .
Trimming of longer RNA molecules by either RNase A or T1 leaves ends (3′P and 5′OH) that are incompatible with ligation. The order of enzymatic repair reactions should therefore be reversed (5′ and 3′ thermosensitive alkaline phosphatase (TSAP) dephos phorylation first, then 5′ T4 polynucleotide kinase (PNK) phos phorylation). Short RNAs with unusual end modifications may require the inclusion of additional enzymatic steps. Note that, although this protocol is predicted to yield only chimeras with the miRNA sequence positioned 5′ to the mRNAderived sequence ( Fig. 2) , the opposite orientation was also recovered at lower frequency.
CLASH controls.
In CLASH experiments, three kinds of controls are useful: (i) a negative control sample prepared from the cell line without tagged AGO protein. This is an important control that indicates the amount of RNA background. This control sample should give little, if any, signal by autoradiography (Fig. 3a) , and it should not give rise to much PCR product (Fig. 3b) . However, this is not a very good negative control for the analysis of sequencing data. (ii) A useful negative control for the bioinformatic analysis is a sample prepared from a cell line that carries a different tagged protein, preferentially one that is involved in a different biological process. This can give information on the common, unspecific RNA contaminants. (iii) A control sample prepared with mixed lysates of different species (see 'Purification of AGO1 complexes' above and ref. 12 for more details). This is an especially useful sample when modifying the experimental protocol described here, as it gives information on the recovery of unspecific RNARNA complexes that do not originate from physiological interactions. 
Bioinformatic analysis (Step 81).
Basic bioinformatic analysis of CLASH data involves the following: (i) preprocessing of Illumina sequence reads (i.e., quality control and linker trimming); (ii) mapping reads to the transcriptomic or genomic database; (iii) identifying the chimeric reads defined as two highquality hits to distinct regions of the database; and (iv) determining the RNARNA interaction sites and basepairing by the RNA second ary structure prediction algorithms.
The bioinformatic pipeline for analysis of the AGO1 CLASH data was described in ref. 12 . More detailed descriptions of the bioinformatics, further discussion of variants in the analyses and their influence on its outcome are described in ref. 16 IgG antibody from rabbit serum (SigmaAldrich, cat. no. I5006) rATP, 100 mM (Promega, cat. no. E6011). Prepare aliquots and store them at −20 °C for at least 1 year  crItIcal Avoid repeated thawing and freezing. ATP, 10 mM (New England BioLabs, supplied with T4 RNA ligase 1). Store it at −20 °C, or for longterm storage (more than 1 month), store it at −70 °C. BSA (SigmaAldrich, cat. no. A3294) dissolved in water at 10 mg ml −1 Guanidine hydrochloride (SigmaAldrich, cat. no. G4505) ! cautIon This reagent is harmful if swallowed. Ninitrilotriacetic acid (NTA) Superflow beads (Qiagen, cat. no. 30410) RNasin (Promega, cat. no. N2111) PEG 8000 (SigmaAldrich, cat. no. P1458) miRCat33 conversion oligos pack (Illuminacompatible 3′ adapter and reverse transcription (RT) primer; Integrated DNA Technologies, cat. no. 51011310); stock concentration = 10 µM in water. After dissolving, prepare aliquots and store them at −80 °C for at least 1 year  crItIcal Always use fresh aliquots. Illuminacompatible L5 adapters (r stands for ribonucleotide, rN indicates a random ribonucleotide): 5′invddTACACrGrArCrGrCrUrCrUrUrCrCr GrArUrCrUrNrNrNbar code3′, list of bar codes used: L5Aa: 5′rUrArA rGrC3′OH; L5Ab: 5′rArUrUrArGrC3′OH; L5Ac: 5′rGrCrGrCrArGrC3′OH; L5Cc: 5′rArCrTrCrArGrC3′OH; L5Cd: 5′rGrArCrTrTrArGrC3′OH (Integrated DNA Technologies, custom order); stock concentration = 100 µM in water. Prepare aliquots after dissolving. They can be stored at −80 °C for at least 1 year  crItIcal Always use fresh aliquots of the linker. P5 PCR primer: 5′AATGATACGGCGACCACCGAGATCTACACTCTTT CCCTACACGACGCTCTTCCGATCT3′ (Integrated DNA Technologies, custom order), stock concentration = 10 µM in water. After dissolving, prepare aliquots and store them at −20 °C for at least 3 years PE_miRCat_PCR primer: 5′CAAGCAGAAGACGGCATACGAGATCG GTCTCGGCATTCCTGGCCTTGGCACCCGAGAATTCC3′ (Integrated DNA Technologies, custom order), stock concentration = 10 µM in water. After dissolving, prepare aliquots and store them at −20 °C for at least 3 years 
2|
The next day, induce the cells for PTH-AGO1 production with doxycycline (final concentration 0.5 µg ml −1 ) for 36 h. Use four plates per CLASH sample.
uV cross-linking • tIMInG ~10 min per clasH sample 3| At this stage, the cells should be ~90% confluent. Briefly wash the growing cells once with room-temperature DPBS.
4|
Place the culture plates without lids on an ice tray and into the Stratalinker. Irradiate at λ = 254 nm with a power setting of 400 mJ cm −2 .  crItIcal step Proceed with one plate at a time to reduce the time between DPBS washing and cell lysis, thus limiting cell exposure to changed conditions. cell lysis • tIMInG 1 h 5| Directly after cross-linking, lyse the cells on the dish by adding 2.5 ml of ice-cold lysis buffer; incubate the cells for 5 min on ice.
6| When all the dishes are ready, scrape the cells and collect the pooled lysates into 15-ml conical tubes.
7|
Incubate the samples for a further 10 min on ice, and then centrifuge them at 6,400g for 30 min at 4 °C. Prepare the WB sample ('IgG-Dynabeads input') by boiling 15 µl of lysate with 5 µl of NuPAGE LDS sample buffer for 5 min; store it at −20 °C until further use at Step 25.  pause poInt Cell lysates can either be used directly or divided into aliquots, frozen in liquid nitrogen and stored at −80 °C for up to 6 months.
IgG-Dynabeads loading and washing • tIMInG 90 min 8|
Wash the IgG-coated Dynabeads three times with 5 ml of ice-cold DPBS.  crItIcal step Washing the beads directly before loading is essential for the removal of IgG released from the beads during storage. Free IgG competes with IgG-coated beads, which decreases the AGO-binding efficiency.
9|
Add 20 mg of IgG-Dynabeads to each sample of freshly prepared or thawed lysates from Step 7. Incubate the samples with rotation for 40 min at 4 °C.  crItIcal step Frozen lysates should be thawed slowly on ice. 11| Wash the beads briefly by resuspending them in 10 ml of ice-cold LS-IgG buffer, allow the beads to pellet in the magnetic rack and discard the supernatant.
10|

12|
Wash the beads twice with ice-cold HS-IgG buffer, this time incubating them for 5 min in the buffer with rotation at 4 °C. Pellet the beads and discard the supernatant.
13|
Wash the beads once briefly with 10 ml of ice-cold LS-IgG buffer. Pellet the beads and discard the supernatant.
14|
Wash the beads once briefly with 10 ml of ice-cold PNK-WB buffer. Pellet the beads and discard the supernatant.
15|
Gently resuspend the beads with a pipette in 1 ml of ice-cold PNK-WB buffer, and transfer them to 1.5-ml microcentrifuge tubes. Pellet the beads in the magnetic rack and discard the supernatant.
rnase digestion on Dynabeads • tIMInG 15 min 16| Prepare the RNase digestion buffer by adding 1 µl of diluted RNace-IT (0.5 U) to 500 µl of prewarmed PNK-WB buffer per sample.  crItIcal step This step might require optimization; more details are given in the Experimental design section.
17| Add prepared RNase digestion buffer from
Step 16 to the IgG-Dynabeads from Step 15 and incubate for 7 min at 20 °C.  crItIcal step During the digestion, tap the samples gently every 30 s to prevent Dynabeads from settling.
18|
Place the samples briefly on ice to slow down the reaction, and then settle the beads on the magnetic rack. Remove the RNase digestion buffer completely and discard it.
elution from IgG-Dynabeads • tIMInG 40 min 19| Add 500 µl of Ni-WBI buffer to the beads and incubate the mixture for 10 min at room temperature with rotation.
20|
Pellet the beads and collect the supernatant.
21|
Repeat the elution twice more, once with 500 µl and once with 1 ml of Ni-WBI buffer. Pool all the eluate fractions together. Prepare the WB sample ('Ni-NTA input') as follows: 10 µl eluate + 90 µl water + 100 µl 10% (wt/vol) TCA, incubate it for 40 min on ice and then proceed as in Steps 48-52. Store the sample at −20 °C until further use at Step 25.
22| Wash the Dynabeads with 1 ml of PNK-WB and resuspend the beads in 1 ml of PNK-WB. Prepare the WB sample ('IgG-Dynabeads beads') by mixing 15 µl of IgG-Dynabeads suspension + 135 µl water + 50 µl NuPAGE LDS sample buffer, boil it for 5 min and store it at −20 °C until further use at Step 25. Use 20 µl per gel lane.
ni-nta agarose loading and washing • tIMInG 3 h, plus 6 h for WB (optional) 23|
Wash Ni-NTA beads twice with Ni-WBI buffer and prepare a 50% bead suspension in Ni-WBI buffer for all the samples together. Add 80 µl of prepared Ni-NTA suspension to each eluate from Step 21 and incubate for 2 h at 4 °C with rotation.
24|
Spin the beads at 1,000g for 10 s at 4 °C and gently aspirate the supernatant. Prepare the WB sample ('Ni-NTA flow through') by using 10 µl of supernatant, as described in Step 21.
25|
Perform WB (optional) to estimate AGO recovery during purification steps, by using WB samples prepared in Steps 7, 10, 21, 22 and 24. SDS-PAGE and transfer procedures are described in Steps 53 and 54. For the tagged AGO detection, use peroxidase-anti-peroxidase soluble complex antibody (prepare a 1:10,000 dilution in 5% nonfat dry milk in DPBS (wt/vol) and incubate the membrane for 1 h at room temperature with rotation; detect peroxidase coupled antibody using enhanced chemiluminescence (ECL) solution).
26|
Wash the beads twice with 1 ml of ice-cold Ni-WBI for 10 min at 4 °C with rotation.
27|
Transfer the beads to spin columns. Keep the columns in 1.5-ml microcentifuge tubes.
28|
Wash the beads twice with 0.75 ml of ice-cold Ni-WBII, and discard the supernatant. The same wash collection tubes can be used multiple times throughout the procedure. 
31|
Remove the snap cap and wash the beads twice with 0.5 ml of ice-cold buffer Ni-WBI; discard the washes.  crItIcal step To prevent quick dripping from the column, open the lid first, then open the snap cap and quickly place the column in the microcentrifuge collection tube.  crItIcal step To limit the column contact area with Ni-WBI, add the buffer directly to the bottom of the column. Ni-WBI has to be rinsed off well, as it contains guanidine hydrochloride, which can affect the subsequent enzymatic reactions.
32|
Wash the beads twice with 0.75 ml of ice-cold buffer Ni-WBII and discard the washes.
33|
Wash the beads 3 times with 0.75 ml of ice-cold buffer PNK-WB and discard the washes.
Inter-molecular rna-rna ligation • tIMInG overnight 34| Close the bottom of the column with a snap cap, and add 160 µl of ligation mixture prepared in bulk for all the samples together; the volumes per sample are given below. Incubate the samples overnight at 16 °C with gentle rotation. Mix total volume 80 ! cautIon Always be careful when you are working with radioactive material. Consult local and institutional rules for detailed guidelines.
41|
Wash the beads extensively with Ni-WBI; each wash volume is 0.5 ml.  crItIcal step Wash the beads multiple times at this stage to remove free 32 P-γ-ATP; reduce the risk of exposure to radioactivity and contamination. Monitor the radioactivity in the flow-through and repeat washes until this falls to ~10 counts per minute (c.p.m.).
42| Wash the beads as in Steps 31-33.
elution of ptH-aGo-rna complexes from ni-nta beads • tIMInG 30 min 43| Add 200 µl of Ni-EB buffer to the beads, close the snap cap and incubate in thermoblock setup for 5 min at room temperature with gentle mixing.
44| Collect the supernatant.
45|
Repeat the elution twice more, once with 200 µl and once with 600 µl of Ni-EB buffer.
46| Pool all the eluate fractions together (total volume ~1 ml).
tca precipitation • tIMInG 2 h 47| Add 2 µg of BSA and 200 µl of 100% TCA and incubate it for 40 min on ice.
48|
Centrifuge the samples in a tabletop centrifuge at 20,000g for 30 min at 4 °C.
49| Discard the supernatant. ! cautIon Note that at this stage the supernatant can still be radioactive, as it contains unincorporated 32 P-γ-ATP.
50|
Wash the pellets containing protein-RNA complexes twice with 1 ml of ice-cold acetone. Vortex the samples well during each wash, and spin the pellets with maximum speed (20,000g) for 10 min at 4 °C. Discard the supernatants.
51|
Dry the pellets at room temperature (~5 min; or at 37 °C, but do not overdry them).
52|
Resuspend the pellets in 15 µl of water, add 5 µl of 4 × NuPAGE LDS sample buffer and heat the samples for 10 min at 65 °C.  crItIcal step Protein pellets after TCA precipitation are easier to resuspend in water than in prediluted 1× NuPAGE LDS sample buffer.  crItIcal step The NuPAGE buffer system is quite resistant to small changes in the pH of the samples, but carefully observe the color of the samples in the NuPAGE LDS sample buffer. If it changes, add 1 µl, or more, of 1 M Tris (pH 7.8) until the color comes back to normal.
 pause poInt Prepared samples can be frozen at −20 °C for a few days. ? trouBlesHootInG sDs-paGe and transfer of protein-rna complexes • tIMInG 4.5 h 53| Thaw the samples, separate the proteins and prestained protein standard on the 4-12% (wt/vol) polyacrylamide Bis-Tris NuPAGE gel with NuPAGE SDS-MOPS running buffer; run the samples at a constant voltage (150 V) until the dye reaches the bottom of the gel (~30 min).  crItIcal step It is important to use NuPAGE SDS-MOPS buffer as, unlike homemade buffers, it does not change its pH substantially during the run. An increase in buffer pH can cause RNA degradation.  crItIcal step To reduce the risk of sample cross-contamination, separate neighboring samples with empty lanes.
? trouBlesHootInG 54| Transfer gel-separated protein-RNA complexes to the nitrocellulose membrane in the cooled wet-transfer tank by using NuPage transfer buffer supplemented with 10% (vol/vol) methanol for 2 h at constant voltage (100 V).
55| Air-dry the nitrocellulose membrane for 30 s, wrap it in cling film, attach the phosphorescent ruler and expose it on the autoradiography film for 1 h (or longer, as needed).  crItIcal step Attaching the phosphorescent ruler to the cling film before exposition is crucial, as it is the only way to precisely align the nitrocellulose membrane with the exposed autoradiography film.  pause poInt The nitrocellulose membrane can be frozen at −20 °C for at least a week.
? trouBlesHootInG rna purification • tIMInG 5 h to overnight, plus 4 h 56| Carefully align the nitrocellulose membrane with the developed autoradiography film by using the signal from the phosphorescent ruler. Cut out the radioactive bands with disposable scalpels according to the instructions included in Figure 3a .
57| Place the cut-out membrane pieces in separate 1.5-ml microcentrifuge tubes. Add 400 µl of proteinase K buffer and 100 µg of proteinase K per tube; incubate the samples in the thermoblock setup for gentle mixing for 2 h at 55 °C.  crItIcal step After that time, check the membrane for remaining radioactivity, which should be low in comparison with the solution.
? trouBlesHootInG 58| Discard the membrane and perform PCI extraction of RNA from solution. Add 50 µl of 3 M sodium acetate (pH 5.5), and 500 µl of PCI, and then vortex the samples vigorously for 30 s. ! cautIon Phenol is toxic on inhalation, on contact with skin or if swallowed; it causes severe skin burns and eye damage. Use a hood, protective clothing, eye protection and gloves.
59|
Centrifuge the samples at maximum speed (20,000g) in a tabletop centrifuge for 5 min at room temperature. Immediately collect the upper aqueous phase (~350 µl). Check the lower organic phase for remaining radioactivity, which should be low in comparison with the aqueous phase.  crItIcal step Be very careful not to aspirate the lower organic fraction. 63| Air-dry the pellets (~5 min, alternatively at 37 °C, do not overdry the pellets 69| Add 1 µl of Superscript III reverse transcriptase, and incubate the samples for 60 min at 50 °C.
70|
To inactivate reverse transcriptase, incubate the samples for 15 min at 65 °C.
71|
To degrade template RNA, add 2 ml of RNase H and incubate the samples for 30 min at 37 °C.  pause poInt Prepared cDNA can be stored indefinitely at −20 °C.
pcr amplification of the library • tIMInG 1 h 72| To PCR-amplify the library, prepare 200 ml of PCR mixture for each sample as follows, and divide it into four PCR tubes for amplification.  crItIcal step Limit the number of PCR cycles to reduce the proportion of PCR duplicates in the sequencing result.  crItIcal step To confirm the quality of the library, a small-scale PCR amplification can initially be performed with 1 µl of template. However, in this case, before high-throughput sequencing, increase the sequencing depth by PCR amplification of the entire cDNA library. It is also informative to set up an additional PCR with miRNA-specific primers (see ANTICIPATED RESULTS section).
 pause poInt Samples can be frozen and stored for up to a year at −20 °C. However, freezing is not recommended if library quality will be checked by cloning and small-scale sequencing (in Step 79). In this case, follow the PROCEDURE continuously to
Step 77 or 79.
size selection of the Dna fragments in the library • tIMInG 4 h 73| Prepare the 3% (wt/vol) MetaPhor agarose gel in TBE buffer with SYBRSafe according to the manufacturer's instructions. The gel can be prepared in advance (i.e., 1 d before) and stored at 4 °C wrapped in cling film.
74| Concentrate the DNA library from
Step 72 by using the MinElute PCR purification kit according to the manufacturer's instructions. Elute the sample with 20 µl of buffer EB provided with the kit. Add 4 µl of 6× DNA loading dye to each sample.
75|
Place the gel tank on ice, load the samples and the 50-bp GeneRuler DNA ladder and run the gel at constant voltage (80 V) for ~2 h until bromophenol blue reaches the edge of the gel.  crItIcal step Unless your samples carry bar-coded adapters, separate neighboring samples with empty lanes to reduce the risk of cross-contamination. ? trouBlesHootInG 76| Scan the gel on the gel scanner and print the scan in its original size. Place the print underneath the transparency film and gel on its top. Carefully overlay the gel with the scan and cut-out gel slices with DNA fragments of desired length according to the instructions included in Figure 3b and in the ANTICIPATED RESULTS section.  crItIcal step This is an important step in the library preparation, as it allows enrichment of chimeric reads versus miRNA reads. ? trouBlesHootInG 77| Isolate DNA fragments from the gel by using the MinElute Gel extraction kit according to the manufacturer's instructions. Elute the sample with 20 µl of buffer EB from the kit.  crItIcal step To increase the cloning efficiency, dissolve the agarose slice in QG buffer (part of the kit) at room temperature, instead of 50 °C suggested by the kit manufacturer.  pause poInt It is possible to freeze the sample at −20 °C at this point and come back to the cloning procedure the next day. However, this can affect the cloning efficiency.
78|
Measure the concentration of the cDNA library by using Qubit Fluorometer and Qubit dsDNA HS assay kit according to the manufacturer's instructions. The library is ready for high-throughput sequencing.
cloning of the cDna library and small-scale sequencing (optional) • tIMInG variable 79| To check the quality of the cDNA library by small-scale sequencing, set up cloning reaction by using the TOPO-TA cloning kit according to the manufacturer's instructions. Use 2 µl of the library from Step 78 per 6-µl cloning mixture. Transform the Top10-competent bacteria that are supplied with the kit, and grow them on the LB agar plates with ampicillin.  crItIcal step Handle the Top10 bacteria supplied with the TOPO-TA cloning kit with utmost care, as they are extremely sensitive.
? trouBlesHootInG 80| Send the colonies or purified plasmids for Sanger sequencing. 
Bioinformatic analysis
antIcIpateD results
The CLASH procedure is long and contains relatively few steps at which progress can be controlled. It is therefore useful to collect the samples from all the purification fractions for clues that may help future troubleshooting.
step 7
Before starting the CLASH procedure, it is worth determining the expression level of the tagged AGO protein by WB. The aim should be to express the tagged protein at close to endogenous levels. Overexpression risks generating spurious binding sites. Note that the protein A tag should be cleaved in order to compare the amount of tagged and endogenous proteins, as it will bind to antibodies used for WB.
step 25
By comparing the amount of tagged AGO in the cell lysate with AGO remaining in the flow-through from IgG-Dynabeads loading, it is possible to estimate the Dynabeads' IgG-coating efficiency and the percentage of protein bound by the IgG-Dynabeads relative to the cell lysate input. Independently of the amount of the IgG beads used per sample, we routinely observe ~30% protein loss at this stage (Fig. 3c) . At the stage of Ni-NTA loading, we also observe up to 25% loss in the amount of AGO (Fig. 3c) .
step 50
After TCA precipitation, higher radioactivity of the samples than the negative control prepared from the cell line without tagged AGO protein is expected.
step 56
The strength of the signal obtained by autoradiography can vary markedly from experiment to experiment. However, with successful procedure, a clear signal should be visible within 1 h. There should be a single main band in each sample lane corresponding to cross-linked AGO-RNA complexes at the level of the orange band in the prestained SeeBlue Plus 2 standard. An additional band is frequently visible above this, corresponding to AGO-RNA complexes. The negative control prepared from the cell line without tagged AGO protein should not give clear radioactive bands, but some signal in the whole lane may be visible after an overnight exposure because of background RNA.
step 76
A typical agarose gel picture is presented in Figure 3b . A fast migrating band of ~120 bp is frequently visible, both in the samples and negative controls. This corresponds to the ligated adapter dimers, and its intensity varies markedly between experiments. It is expected that there will be a broad band, relatively sharper at the bottom and smeared at the top, 20 bp above that. The lower part of the band mostly corresponds to cloned miRNAs, whereas the upper, smeared part is enriched for targets and chimeric sequences. This upper band should appear only in the cross-linked samples. Separately isolating the DNA fragments of different sizes allows enrichment for the target and chimeric sequences in the sequence data. We generally use threefold more of the upper band (UB: targets + chimeras) than the lower band (LB: miRNAs). In case of doubts, preparing additional control PCR reactions with primers that amplify a specific miRNA can confirm that the cross-linking and linker ligations were successful. For studies on HEK 293 cells, we used primers specific for the highly expressed miR-16; a typical gel picture is shown in Figure 3d .
step 78
Because the amount of cDNA in the library depends on multiple factors, it is difficult to give any expected concentration.
To have enough material for the small-scale and high-throughput sequencing without creating unnecessary PCR duplicates, adjust the number of PCR cycles to obtain ~20-80 ng of DNA.
step 80
A small-scale sequencing analysis should provide the following information: (i) types of RNAs present in the sequencing data: expect many miRNAs for AGO-CLASH; (ii) the average length of cDNA inserts, which reflects the effectiveness of RNase treatment; and (iii) the presence of bacterial rRNA contamination.
